Showing results (931-940 of 956) with videos related to
Sort By:
Pageof 96
Communications Medicine|April 29, 2026
Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVIDMark A Faghy, Rob C I Wüst, Daniel M Altmann, et al.JAMA Surgery|August 16, 2013
Successful nonoperative management of the most severe blunt renal injuries: a multicenter study of the research consortium of New England Centers for TraumaGwendolyn M van der Wilden, George C Velmahos, D'Andrea K Joseph, et al.Lancet (London, England)|June 18, 2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial, Haleema Shakur, Ian Roberts, et al.Transboundary and Emerging Diseases|January 10, 2020
Serological surveillance and clinical investigation of glanders among indigenous equines in India from 2015 to 2018Harisankar Singha, Karuppusamy Shanmugasundaram, Bhupendra Nath Tripathi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinomaAwalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.Journal of Critical Care|March 16, 2024
Assessment of the comparative agreement between chest radiographs and CT scans in intensive care unitsDaniel Brooks, Stephen E Wright, Anna Beattie, et al.Cancer Discovery|May 16, 2012
The BATTLE trial: personalizing therapy for lung cancerEdward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.NPJ Precision Oncology|May 4, 2021
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site studyPatrick Leo, Andrew Janowczyk, Robin Elliott, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2013
Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trialGeorge R Blumenschein, Pierre Saintigny, Suyu Liu, et al.Scientific Reports|June 15, 2017
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trialSurendra K Sharma, Kiran Katoch, Rohit Sarin, et al.Pageof 96